NEW

Fusion Robotics Receives 510(k) Clearance for Spinal Navigation and Robotics System

Fusion Robotics LLC, a spinal robotics and navigation company has received 510(k) clearance to market its 3D imaging compatible navigation and robotic targeting system for spine surgery in the U.S. market.

ECRI and oneSOURCE Plan Alerts Management Collaboration

ECRI and oneSOURCE Document Management Services have announced a joint collaboration focused on improving medical device safety and responsiveness of health care facilities.

TransEnterix Announces Name Change, Introduces a New Category of Surgery

The name change reflects the company’s broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.

Fujifilm Systems Integration Leads AIA-Accredited Course

During this one hour course, participants will learn about the importance of continuing to digitize systems and processes in the OR, the role digitization plays in ensuring that various technologies used during procedures are connected and accessible, and why it’s important to understand this evolution as architects and equipment planners.

Renishaw’s integrated neurosurgery solution cleared for sale in U.S.

The Food and Drug Administration (FDA) has cleared the use of Renishaw’s neuromate® Gen III surgical robot with the neuroinspire™ surgical planning software in the United States. Both were previously cleared for use separately, but not in combination. This latest clearance means that neurosurgeons across America will be able to deliver surgical plans created using neuroinspire software directly using the neuromate surgical robot, helping to improve patient outcomes.

 

Renishaw’s neuromate robotic system for stereotactic neurosurgery provides a platform solution for several functional neurosurgical procedures. The neuromate robot has been used in thousands of procedures such as deep brain stimulation (DBS), stereoelectroencephalography (SEEG), biopsy and more.

 

The neuroinspire software assists with the planning of stereotactic procedures. Using 3D patient scan data, neuroinspiresoftware allows neurosurgeons to clearly visualise the safest surgical route to target. The software also allows neurosurgeons to visualise an image of implantable instruments in position along with a customisable safety zone.

 

Before obtaining this latest clearance, plans generated using neuroinspire software could be manually transferred onto a traditional stereotactic frame. With this latest clearance, customers can now export surgical plans from neuroinspiresoftware directly to the neuromate robot for efficient procedure execution.

 

“Hospitals in the UK and the rest of Europe are already using the neuromate surgical robot in combination with neuroinspiresoftware,” explained Andrew Dissington, Senior Project Manager at Renishaw. “Now, patients across the U.S. will be able to benefit from improved neuromate robot procedures for Parkinson’s, epilepsy and brain tumours.”

 

“SEEG procedures for epilepsy can involve 20 electrodes being implanted into the brain,” added Dissington. “Robotic surgery is much quicker to deliver than manually using a frame. The approval means that existing neuromate surgical robot users are able to take advantage of Renishaw’s intuitive, user-friendly software package.”

 

Renishaw offers a complete package from planning to delivery, which includes the supply of consumables and training. The company regularly updates its software offering, which can also be customised to meet specific needs using add-on modules.

 

For more information on Renishaw’s products for stereotactic neurosurgery, visit www.renishaw.com/neuro.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X